DGCR.F Stock Overview
9342-8530 Québec Inc., a life sciences company, develops and commercializes products relating to the diagnosis of cancer in Canada.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
9342-8530 Québec Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.0001 |
52 Week Low | US$0.000001 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | -99.91% |
Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
DGCR.F | US Biotechs | US Market | |
---|---|---|---|
7D | 0% | -4.5% | -1.1% |
1Y | n/a | 3.4% | 25.8% |
Rentabilidad frente al sector: Datos insuficientes para determinar los resultados de DGCR.F en comparación con el sector US Biotechs .
Rentabilidad vs. Mercado: Datos insuficientes para determinar el rendimiento de DGCR.F frente al mercado US.
Price Volatility
DGCR.F volatility | |
---|---|
DGCR.F Average Weekly Movement | n/a |
Biotechs Industry Average Movement | 12.0% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.7% |
10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: DGCR.F no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: Datos insuficientes para determinar el cambio de volatilidad de DGCR.F en el último año.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | n/a | Yves Fradet | https://www.diagnocure.com |
9342-8530 Québec Inc. Fundamentals Summary
DGCR.F fundamental statistics | |
---|---|
Market cap | US$43.00 |
Earnings (TTM) | US$1.99m |
Revenue (TTM) | US$4.86m |
0.0x
P/E Ratio0.0x
P/S RatioIs DGCR.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
DGCR.F income statement (TTM) | |
---|---|
Revenue | CA$6.68m |
Cost of Revenue | -CA$139.13k |
Gross Profit | CA$6.82m |
Other Expenses | CA$4.08m |
Earnings | CA$2.74m |
Last Reported Earnings
Jul 31, 2016
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did DGCR.F perform over the long term?
See historical performance and comparison